Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.

Pharmaceutical

Biotest

Michael Ramroth

Christina Erb

Josefine Buth

Stephan Fleck

Oliver Hein

Jörg Schüttrumpf

Peter Janssen

Ainhoa Mendizabal Zubiaga

The board of directors at Biotest is made up of experienced professionals from a variety of fields. Laboratory assistants, undergraduate engineers, supervisors, and baristas have all served on the board at one point or another. This experience, coupled with a strong educational background from universities like The University of Queensland and UCSI, gives the board a well-rounded perspective on the company's operations.

Board of Directors

Board of Directors

About

Team members